Clinical Trials Update: Dec. 27, 2005

Erectile Dysfunction Multiple Sclerosis Social Anxiety Disorder (SAD)

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Erectile Dysfunction

This study will evaluate the safety and effectiveness of an investigational medication to treat male erectile dysfunction. Candidates may include men 19 years or older in a stable relationship with a female partner, and a history of erectile dysfunction of at least three months. Research site located in Aventura, Fla.

More Information

Please see http://www.centerwatch.com/patient/studies/cat371.html.

-----

Multiple Sclerosis

This research study is being conducted in the U.S. and Europe to evaluate the safety and efficacy of daclizumab for the treatment of multiple sclerosis (MS). Patients must be 18 years to 55 years of age, on stable interferon-beta therapy and have the ability to walk at least 20 feet (66 meters), with assistance if necessary. Research site located in Albany, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/cat102.html.

-----

Social Anxiety Disorder (SAD)

Are you anxious in certain social situations? Males or females 18 to 65 years of age may qualify for this study of an investigational medication. Research site located in Media, Penn.

More Information

Please see http://www.centerwatch.com/patient/studies/cat483.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News